CDNA CareDx, Inc.
$50.26▲ +0.48%
Healthcare
Other
After hours
$50.82▲ +1.11%
Sep 11, 7:57 PM ET
Volume 663.1K
Avg Volume (10D) 1.12M
Key Metrics & Fundamentals
Market Cap
$2.60B
P/E Ratio
24.2
Div Yield
–%
52W Range
13.39 - 53.67
% vs 50 MA
18.52%
% vs 200 MA
95.24%
RSI-14
62.4
MACD Histogram
-0.4800
Beta (1Y vs SPY)
1.37
Free Cash Flow
$28.75M
Gross Rev
$131.95M
Gross Profit
$96.98M
EBITDA
-$108.66M
COGS
$34.97M
Operating Exp
$96.73M
Operating Income
$257,000
EBIT
$257,000
Pretax Income
$114.52M
Net Income
$110.64M
EPS (Diluted)
2.07
Price & Volume History
Loading chart…
Recent News

Oil Surge Continues on Escalating Middle East Crisis: 4 Defensive Picks
Zacks · Sep 9, 2026 12:41 PM

Are Medical Stocks Lagging CareDx (CDNA) This Year?
Zacks · Sep 8, 2026 1:40 PM
Canaccord Genuity Initiates CareDx at Buy With $65 Price Target
MT Newswires · Sep 2, 2026 10:26 AM

CareDx (CDNA) is a Great Momentum Stock: Should You Buy?
Zacks · Aug 27, 2026 4:00 PM

Zacks Industry Outlook CareDx, BrightSpring and PACS
Zacks · Aug 25, 2026 8:53 AM

3 Medical Service Stocks Resilient Amid Persistent Workforce Shortage
Zacks · Aug 24, 2026 1:24 PM

CareDx (CDNA) Shares Jumped, So What Is Driving Attention Now?
Simply Wall St. · Aug 23, 2026 10:08 AM

Is CareDx (CDNA) Fully Priced After Its Strong Three Year Run?
Simply Wall St. · Aug 22, 2026 4:08 PM

Is MacroGenics (MGNX) Stock Outpacing Its Medical Peers This Year?
Zacks · Aug 20, 2026 1:40 PM

Baron Discovery Fund Gains from Strategic Accumulation of CareDx (CDNA)
Insider Monkey · Aug 12, 2026 1:47 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See CDNA's money flow as a full page
Social Sentiment
No Reddit posts found for CDNA.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.